Clinical Trial Update: Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury [Phase 1]

View source ↗

Summary

Phase 1 safety observation update on an hESC-derived mesenchymal stem cell–like therapy for meniscal injury. The status of the study is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniscal Injury

Drugs mentioned

• hESC Derived MSC Like Cell

Snippet

Sponsor: Tongji Hospital | Conditions: Meniscus Injury | Phase 1 | Status: UNKNOWN